(HealthDay)—Outcomes-based pricing does not reduce the costs of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, according to a research letter published online April 3 in the Annals of Internal Medicine.
Apr 3, 2018
0
3
Prescription drug consumers confounded by the cost of their medications can get a peek behind the curtain thanks to new Washington University in St. Louis research into the complex "co-opetition"—cooperation and competition—among ...
Mar 30, 2018
0
3
Drug manufacturing and pricing vaulted into the news several years ago when a privately held company raised the price of a drug used for infections from US$13.50 to $750 for one pill.
Mar 28, 2018
0
2
A Stanford researcher and his colleague got access to data showing the inner workings of an influential committee advising Medicare. They found that bias among its members has different effects from what critics claim.
Mar 8, 2018
0
3
(HealthDay)—There is significant variation in markup of outpatient oncology services across hospitals in the United States, according to a study published online Feb. 17 in the American Journal of Managed Care.
Mar 5, 2018
0
1
New research from The University of Texas at Dallas supports the growing consensus that pain begins differently for men and women at the cellular level.
Mar 5, 2018
0
616
From April, the UK government's sugar tax will make 500ml bottles of high-sugar drinks cost an extra 14p, and two litre bottles an extra 58p. The higher price is intended to steer people towards choosing lower-sugar drinks. ...
Feb 9, 2018
0
1
Consuming sugar-sweetened drinks is associated with a range of health issues including weight gain and obesity. These are risk factors for diabetes, heart disease, high blood pressure, strokes and certain cancers.
Feb 8, 2018
0
1
(HealthDay)—Americans spent more on health care in 2016, even though their use of health care did not increase, and rising costs are the reason why, a new report shows.
Jan 23, 2018
0
6
A little known pharmaceutical company in Florida has found itself in the eye of a storm following disclosures it raised the price of an old drug used to fight brain tumors by 1,400 percent, from $50 a pill to more than $700.
Jan 5, 2018
0
8
